Evidence map›Paper›PMID 24958148›Full record

ArticleMetabolites2013

Integrative analysis of longitudinal metabolomics data from a personal multi-omics profile.

Larissa Stanberry, George I Mias, Winston Haynes, Roger Higdon, Michael Snyder, Eugene Kolker

Abstract read
In one paragraph

Article in Metabolites, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Longitudinal omics data analysis: approaches and applications.Computational and structural biotechnology journal · 2026
    Review
  2. Article
  3. Article
  4. Multi-Omics Profiling for Health.Molecular & cellular proteomics : MCP · 2023
    Review
  5. Big Data in Gastroenterology Research.International journal of molecular sciences · 2023
    Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Review
  12. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.International journal of molecular sciences · 2019
    Review
  13. Article
  14. Article
  15. From systems biology to P4 medicine: applications in respiratory medicine.European respiratory review : an official journal of the European Respiratory Society · 2018
    Review
  16. Article
  17. Review
  18. -Omic and Electronic Health Record Big Data Analytics for Precision Medicine.IEEE transactions on bio-medical engineering · 2017
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Larissa StanberryBioinformatics and High-throughput Analysis Laboratory, and High-throughput Analysis Core, Seattle Children's Research Institute, Seattle, 98101, USA. larissa.stanberry@seattlechildrens.org.
George I MiasDepartment of Genetics, Stanford University School of Medicine, Palo Alto, CA, 94305, USA. george.mias@stanford.edu.
Winston HaynesBioinformatics and High-throughput Analysis Laboratory, and High-throughput Analysis Core, Seattle Children's Research Institute, Seattle, 98101, USA. mpsnyder@stanford.edu.
Roger HigdonBioinformatics and High-throughput Analysis Laboratory, and High-throughput Analysis Core, Seattle Children's Research Institute, Seattle, 98101, USA. mpsnyder@stanford.edu.
Michael SnyderData-Enabled Life Sciences Alliance (DELSA Global), Seattle, 98101, USA. george.mias@stanford.edu.
Eugene KolkerBioinformatics and High-throughput Analysis Laboratory, and High-throughput Analysis Core, Seattle Children's Research Institute, Seattle, 98101, USA. mpsnyder@stanford.edu.

Funding

Coordinating Center for Beta Cell Biology ConsortiumU01DK072473 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 2005 to 2014
$61.0M
Human Genome Array: Technology for Functional AnalysisP50HG002357 · NHGRI · YALE UNIVERSITY · PI SNYDER, MICHAEL P. · 2001 to 2010
$31.9M
Signaling and Epigenetic Control of Beta Cell Development and RegenerationU01DK089571 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI ZARET, KENNETH · 2010 to 2011
$1.6M
Integrative Dynamic Omics Profiling: A First Step Towards Personalized MedicineR00HG007065 · NHGRI · MICHIGAN STATE UNIVERSITY · PI MIAS, GEORGE IOANNOU · 2014 to 2016
$745k
Integrative Dynamic Omics Profiling: A First Step Towards Personalized MedicineK99HG007065 · NHGRI · STANFORD UNIVERSITY · PI MIAS, GEORGE IOANNOU · 2013 to 2013
$90k
NHGRI NIH HHS K99 HG007065NHGRI NIH HHS P50 HG002357NHGRI NIH HHS R00 HG007065NIDDK NIH HHS U01 DK072473NIDDK NIH HHS U01 DK089571
6 · The paper itself

Abstract

The integrative personal omics profile (iPOP) is a pioneering study that combines genomics, transcriptomics, proteomics, metabolomics and autoantibody profiles from a single individual over a 14-month period. The observation period includes two episodes of viral infection: a human rhinovirus and a respiratory syncytial virus. The profile studies give an informative snapshot into the biological functioning of an organism. We hypothesize that pathway expression levels are associated with disease status. To test this hypothesis, we use biological pathways to integrate metabolomics and proteomics iPOP data. The approach computes the pathways' differential expression levels at each time point, while taking into account the pathway structure and the longitudinal design. The resulting pathway levels show strong association with the disease status. Further, we identify temporal patterns in metabolite expression levels. The changes in metabolite expression levels also appear to be consistent with the disease status. The results of the integrative analysis suggest that changes in biological pathways may be used to predict and monitor the disease. The iPOP experimental design, data acquisition and analysis issues are discussed within the broader context of personal profiling.

Identifiers

PMID24958148
PMCPMC3901289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.